In the event, this patient has no evidence of disease recurrence after a follow-up of 6 years: in spite of the fact that point mutations in several key melanoma genes (NF1, PTEN, MET and KIT) and the high number of SCNAs made us speculate that this tumor, though thin, might have become a fast-growing melanoma. This evidence concerns the gene MET and melanoma.